Enzolytics
Manufacturing · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
PO Box 5756, Frisco, Texas, United State...Website
www.enzolytics.comRevenue
<$5 MillionIndustry
About Enzolytics
Enzolytics Org Chart
Is Enzolytics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Enzolytics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Enzolytics
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Enzolytics recently announced quarterly report
Check out if Enzolytics is spiking on competitors!
Product Launch: Get notified when Enzolytics launches new products
Click to see if Enzolytics had a recent Job posting/layoffs
Check if Enzolytics has recently received funding, and reach out quickly before it becomes old news!
Enzolytics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Enzolytics
Find more new buyers
Compare Similar Companies to Enzolytics
Compare insights from companies similar to Enzolytics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Enzolytics Tech Stack
A closer look at the technologies used by Enzolytics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Enzolytics
Enzolytics, Inc. is a publicly traded biotech and drug development company based in Texas, focused on the commercialization of proprietary proteins and fully human monoclonal antibodies for the treatment of debilitating infectious diseases. The company's lead compound, ITV-1 (Immune Therapeutic Vaccine-1), is a clinically tested anti-HIV therapeuti... Read More